Engineering Adenoviral Vectors with Improved GBM Selectivity
Glioblastoma (GBM) is the most common and aggressive adult brain cancer with an average survival rate of around 15 months in patients receiving standard treatment. Oncolytic adenovirus expressing therapeutic transgenes represent a promising alternative treatment for GBM. Of the many human adenoviral...
| Published in: | Viruses |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-04-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/15/5/1086 |